Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 Syringes Needles Supplies: Research Protocol Comparison

Reconstitution Syringe 3mL Luer-lock, 18–20G blunt-tip needle Single-draw reconstitution of 5mg vials with 2–2.5mL bacteriostatic water; blunt tip prevents rubber coring 1mL syringe for smaller vials or split reconstitution (increases contamination exposure) 3

This comparison does not assign a generated winner or score.

  • Reconstitution Syringe
  • 3mL Luer-lock, 18–20G blunt-tip needle
  • Single-draw reconstitution of 5mg vials with 2–2.5mL bacteriostatic water; blunt tip prevents rubber coring
  • 1mL syringe for smaller vials or split reconstitution (increases contamination exposure)
  • 3mL with blunt tip is the gold standard. Reduces vial punctures and particulate risk
  • Dosing Syringe
  • 0.3mL or 0.5mL insulin syringe, 29–31G fixed needle
  • Subcutaneous administration at 100–300mcg doses; barrel graduations allow ±0.005mL precision
  • 1mL insulin syringe for doses above 0.5mL (rare in CJC-1295 protocols)
  • 0.3mL–0.5mL insulin syringes are non-negotiable for accurate dosing below 0.5mL
  • Needle Gauge
  • 29G (0.33mm diameter), ½-inch length
  • Balances low tissue trauma with practical draw speed (3–5 sec for 0.2mL)
  • 31G for minimal trauma (slower draw); 27G only if vial stopper is unusually thick
  • 29G is the optimal balance. 31G extends draw time without meaningful trauma reduction
  • Diluent
  • Bacteriostatic water (0.9% benzyl alcohol)
  • Multi-dose stability for 28 days at 2–8°C post-reconstitution
  • Sterile water for injection (single-use within 24 hours only)
  • Bacteriostatic water is required for any protocol extending beyond 48 hours
  • Sterile Supplies
  • Alcohol prep pads (70% isopropyl), sterile gauze
  • Vial stopper sterilization before each puncture; injection site prep and bleeding management
  • None. These are baseline sterility requirements
  • Non-negotiable. Skipping alcohol prep increases contamination risk by 40–60%
  • Storage
  • Refrigeration (2–8°C) for reconstituted peptide; room temp (15–25°C) for unused syringes
  • Maintains peptide stability and prevents bacterial growth in multi-dose vials
  • Freezing unused lyophilized peptide (–20°C) extends shelf life but requires slow thaw before reconstitution
  • Reconstituted CJC-1295 degrades rapidly above 8°C. Refrigeration is mandatory, not optional
More references

Related material